Recombinant multi-species CNOT2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CNOT2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a subunit of the multi-component CCR4-NOT complex. The CCR4-NOT complex regulates mRNA synthesis and degradation and is also thought to be involved in mRNA splicing, transport and localization. The encoded protein interacts with histone deacetylases and functions as a repressor of polymerase II transcription. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Dec 2010]
The Alternative Names of target: 2600016M12Rik,2810470K03Rik,CCR4-NOT transcription complex subunit 2,CCR4-associated factor 2,CDC36,CNOT2,Cnot2,HSPC131,IDNADFS,NOT2,NOT2H

Target products collectionGo to CNOT2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP9120-Ag-1/ GM-Tg-hg-IP9120-Ag-2 Human CNOT2 protein Human
GM-Tg-rg-IP9120-Ag-1/ GM-Tg-rg-IP9120-Ag-2 Rat CNOT2 protein Rat
GM-Tg-mg-IP9120-Ag-1/ GM-Tg-mg-IP9120-Ag-2 Mouse CNOT2 protein Mouse
GM-Tg-cynog-IP9120-Ag-1/ GM-Tg-cynog-IP9120-Ag-2 Cynomolgus/Rhesus macaque CNOT2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP9120-Ag-1/ GM-Tg-felg-IP9120-Ag-2 Feline CNOT2 protein Feline
GM-Tg-cang-IP9120-Ag-1/ GM-Tg-cang-IP9120-Ag-2 Canine CNOT2 protein Canine
GM-Tg-bovg-IP9120-Ag-1/ GM-Tg-bovg-IP9120-Ag-2 Bovine CNOT2 protein Bovine
GM-Tg-equg-IP9120-Ag-1/ GM-Tg-equg-IP9120-Ag-2 Equine CNOT2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP9120-Ag-1/ GM-Tg-hg-IP9120-Ag-2; GM-Tg-rg-IP9120-Ag-1/ GM-Tg-rg-IP9120-Ag-2;
GM-Tg-mg-IP9120-Ag-1/ GM-Tg-mg-IP9120-Ag-2; GM-Tg-cynog-IP9120-Ag-1/ GM-Tg-cynog-IP9120-Ag-2;
GM-Tg-felg-IP9120-Ag-1/ GM-Tg-felg-IP9120-Ag-2; GM-Tg-cang-IP9120-Ag-1/ GM-Tg-cang-IP9120-Ag-2;
GM-Tg-bovg-IP9120-Ag-1/ GM-Tg-bovg-IP9120-Ag-2; GM-Tg-equg-IP9120-Ag-1/ GM-Tg-equg-IP9120-Ag-2
Products Name CNOT2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CNOT2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CNOT2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.